Advancement and prospects of tumor gene therapy
- PMID: 21352695
- PMCID: PMC4013314
- DOI: 10.5732/cjc.010.10074
Advancement and prospects of tumor gene therapy
Abstract
Gene therapy is one of the most attractive fields in tumor therapy. In past decades, significant progress has been achieved. Various approaches, such as viral and non-viral vectors and physical methods, have been developed to make gene delivery safer and more efficient. Several therapeutic strategies have evolved, including gene-based (tumor suppressor genes, suicide genes, antiangiogenic genes, cytokine and oxidative stress-based genes) and RNA-based (antisense oligonucleotides and RNA interference) approaches. In addition, immune response-based strategies (dendritic cell- and T cell-based therapy) are also under investigation in tumor gene therapy. This review highlights the progress and recent developments in gene delivery systems, therapeutic strategies, and possible clinical directions for gene therapy.
References
-
- Blaese RM, Culver KW, Miller AD, et al. T lymphocyte–directed gene therapy for ADA-SCID: initial trial results after 4 years [J] Science. 1995;270(5235):475–480. - PubMed
-
- Edelstein ML, Abedi MR, Wixon J, et al. Gene therapy clinical trials worldwide 1989-2004-an overview [J] J Gene Med. 2004;6(6):597–602. - PubMed
-
- Cotrim AP, Baum BJ. Gene therapy: some history, applications, problems, and prospects [J] Toxicol Pathology. 2008;36(1):97–103. - PubMed
-
- El-Aneed A. An overview of current delivery systems in cancer gene therapy [J] J Control Release. 2004;94(1):1–14. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous